Zydus Lifesciences Shareholding Pattern
- Market cap
- ₹1.16 lakh crore
- P/E
- 25.7
- P/B
- 4.27
- ROE
- 19.7%
- Dividend yield
- 0.09%
As of 30-JUN-2026, promoters held 75.01% of Zydus Lifesciences (0.00 pp from 18-JUN-2026), foreign institutional investors 6.88%, domestic institutions 11.27% and the public 6.83%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Zydus Lifesciences shareholding pattern — frequently asked questions
What is the promoter holding in Zydus Lifesciences?
Promoters held 75.01% of Zydus Lifesciences as of 30-JUN-2026, unchanged from 75.01% in 18-JUN-2026.
How much do FIIs hold in Zydus Lifesciences?
Foreign institutional investors held 6.88% of Zydus Lifesciences as of 30-JUN-2026, a change of -0.01 pp from the previous quarter.
How much do domestic institutions hold in Zydus Lifesciences?
Domestic institutional investors, including mutual funds and insurers, held 11.27% of Zydus Lifesciences as of 30-JUN-2026 (+0.08 pp from the previous quarter).
Who owns Zydus Lifesciences?
As of 30-JUN-2026, Zydus Lifesciences' shareholders were promoters (75.01%), foreign institutional investors 6.88%, domestic institutions 11.27% and the public 6.83%, as filed with the stock exchanges.
Same Data For Peers
Trade Zydus Lifesciences With ATS
Track ZYDUSLIFE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.